American Century Companies’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
JT
RCM
DTC
American Century Companies's PCVX Position: Q2 2026 in Review
American Century Companies increased its Vaxcyte (PCVX) stake by 120% in Q2 2026, buying an estimated $23.2M and bringing the position to 782,184 shares worth $45.5M. The position accounts for 0.02% of the portfolio, ranked #897.
American Century Companies first reported a position in PCVX in Q4 2022 and has held it in 14 quarters since. The position peaked at $60.4M in Q3 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.
- American Century Companies held 782,184 shares of Vaxcyte worth $45.5M as of Q2 2026.
- American Century Companies bought 426,330 Vaxcyte shares in Q2 2026, an estimated $23.2M.
- Vaxcyte made up 0.02% of American Century Companies's portfolio in Q2 2026, its #897 holding.
- American Century Companies first reported a position in Vaxcyte in Q4 2022 and has held it in 14 quarters since.
- American Century Companies's Vaxcyte position peaked at $60.4M in Q3 2024.
- 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.